Related Experiment Video
Updated: Aug 10, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
The mitogenic response of AML blasts to tumor necrosis factor-alpha requires functional c-jun/AP-1
1Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany.
Insights
Tumor Necrosis Factor-alpha (TNF-alpha) stimulates acute myelogenous leukemia (AML) cell proliferation by activating c-jun. Antisense oligomers targeting c-jun blocked this TNF-alpha-induced growth, confirming c-jun
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- The c-jun proto-oncogene is an immediate early response gene.
- c-jun is induced by growth factors and Tumor Necrosis Factor (TNF).
- The role of c-jun in acute myelogenous leukemia (AML) cell proliferation requires elucidation.
Purpose of the Study:
- To investigate the role of c-jun in the mitogenic response of AML blasts to TNF-alpha.
- To determine if c-jun activation is essential for TNF-alpha-mediated growth stimulation in AML.
Main Methods:
- Treatment of primary AML blasts with TNF-alpha.
- Assessment of c-jun transcriptional activation and mRNA accumulation.
- Utilized antisense (AS) oligomers targeting the c-jun translation initiation site to block c-jun/AP-1 activity.
- Compared AS oligomers with sense (S) and non-sense (NS) controls for specificity.
- Evaluated the proliferative response of AML blasts to TNF-alpha under different oligomer treatments.
Main Results:
- TNF-alpha treatment induced c-jun transcriptional activation and mRNA accumulation in AML blasts.
- AS oligomers specifically blocked c-jun/AP-1 translation, while S and NS oligomers did not.
- AML blasts treated with AS c-jun oligomers failed to proliferate in response to TNF-alpha stimulation.
- S and NS oligomers did not inhibit the proliferative response to TNF-alpha.
Conclusions:
- Activation of c-jun/AP-1 is crucial for the proliferative response of AML cells to TNF-alpha.
- c-jun plays a pivotal role in the signaling cascade initiated by TNF-alpha, leading to cell proliferation.
- Targeting c-jun with antisense technology offers a potential strategy for modulating AML cell growth.
Abstract:
The c-jun proto-oncogene belongs to the family of immediate early response genes and is inducible by serum growth factors and Tumor Necrosis Factor (TNF). In the present study we have addressed the role of c-jun for the mitogenic response of primary acute myelogenous leukemia (AML) blasts to TNF-alpha. Our data indicate that TNF-alpha treatment of these cells is associated with transcriptional activation of c-jun and accumulation of c-jun mRNA. In order to elucidate the role of c-jun for TNF-mediated growth stimulation, an antisense (AS) oligomer directed towards the translation initiation site of c-jun was instrumental. Uptake studies of oligonucleotides showed that incorporation of oligomers was maximal at 4 hours. Oligodeoxynucleotides remained stable in these cells for up to 24 hours. Treatment of AML blasts with the AS oligonucleotide resulted in intracellular duplex formation followed by efficient translation blockade of c-jun/AP-1. In contrast, sense (S) and none-sense (NS) oligodeoxynucleotides failed to form intracellular duplexes and also did not interfere with translation of c-jun/AP-1, suggesting specific elimination of c-jun/AP-1 by the AS oligomer. AML blasts cultured in the presence of AS to c-jun, but not of S or NS, failed to proliferatively respond to TNF-alpha stimulation. Taken together, our results indicate that activation of c-jun/AP-1 plays a pivotal role in the signaling cascade initiated by TNF which leads to a proliferative response of its target cells.
Related Concept Videos
Mitogens and the Cell Cycle
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Mitogens and the Cell Cycle

